New imaging study aims to sharpen stroke risk detection
NCT ID NCT07079345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study will use combined PET/MR scans to measure blood flow and glucose metabolism in the brains of 200 people with severe carotid artery narrowing. Participants have already had a mini-stroke or stroke in the past year. The goal is to develop better imaging markers to evaluate disease and guide treatment, not to test a new drug or procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better imaging tools to assess stroke risk and guide treatment decisions for patients with narrowed carotid arteries.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test a new therapy, and the findings may not change current clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PET / MR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xuanwu Hospitail, Capital Medical University
RECRUITINGBeijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentle ear zap supercharge stroke rehab at home?
- Can a Contrast-Free MRI match ultrasound for spotting Stroke-Causing blockages?
- A daily pill that may shield stroke patients from stomach bleeding while on blood thinners
- Wearable patch aims to catch hidden heart rhythms that holter monitors miss
- Triple PET imaging could sharpen epilepsy surgery targeting
- Hidden heart rhythm disorder may be behind many unexplained strokes